![Page 1: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/1.jpg)
Nicole Drake | 22/10/2014 | Mainz, Germany
Making market research actionable: Ensuring that key stakeholders deeply experience and act upon insights
![Page 2: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/2.jpg)
Report, presentation, report…
2
![Page 3: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/3.jpg)
The Cone of Learning
After 2 weeks,
We tend to remember…
P
A
S
S
I
V
E
A
C
T
I
V
E
10% of what we READ
20% of what we HEAR
30% of what we SEE
50% of what we
SEE & HEAR
70% of what
we SAY
90% of what
we SAY & DO
Reading
Hearing
Words
Seeing
Watching a Movie
Looking at an Exhibit
Watching a Demonstration
Seeing it Done on Location
Participating in a Discussion
Giving a Talk
Doing a Dramatic Presentation
Simulating the Real Experience
Doing the Real Thing
Source: Edgar Dale (1969)
3
![Page 4: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/4.jpg)
Connected, but
Not Truly Connected…
4
![Page 5: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/5.jpg)
Global, regional, and local
cross-functional teams unite
5
![Page 6: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/6.jpg)
Increased impact!
6
![Page 7: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/7.jpg)
Case Study:
Allergy Patient
Immersion Session
7
![Page 8: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/8.jpg)
• Map out the patient
journey
• Create a behavioral
patient segmentation
• Generate video footage
for internal educational
purposes
Study Objectives
Business Objectives:
• Develop positioning for
a new product strongly
rooted in patient insights
• Raise internal
awareness about the
impact of the disease on
the patient
Market Research Objectives
8
![Page 9: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/9.jpg)
Patient Immersion Session
OBB Report
Segmentation Workshop
Quantitative Report
Segmentation Videos
Mixed Methodology
9
Online Bulletin Board
Quantitative Survey /
Segmentation
In-home Interview
![Page 10: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/10.jpg)
Patient Immersion Roadmap
10
![Page 11: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/11.jpg)
11
Experience
11
![Page 12: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/12.jpg)
Respiratory Allergy Patient Journey
12 12
![Page 13: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/13.jpg)
Respiratory Allergy Patient Journey
3 - 10 years
3 - 5 years
Diagnosis
85% GP (>UK)
15% Specialist (>IT)
Prescription
Nasal Corticosteroids
and/or Antihistamines
Allergy
Immunotherapy
Diagnosis made
based on:
• Family history
• Skin test
20% of all allergy
patients are initiated
on allergy
immunotherapy
13
First
symptoms <12 y/o
(Seasonal) nasal
congestion, sneezing,
watery eyes
40% of all allergy
patients referred to
specialist due to
frustration with
symptomatic treatments
20% of patients initiated on
allergy immunotherapy do
not show any symptom relief
13
80% of patients successfully
completing allergy immunotherapy
express relief and enthusiasm that
they can finally enjoy being outside
with no to minimal use of
symptomatic treatments
Today
Allergist or
ENT Specialist
Referral
![Page 14: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/14.jpg)
14 14
Patient Visit
14
![Page 15: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/15.jpg)
15 15
Accepting Doubters Optimists Unmotivated
Knowledge Level of
Current Allergies High Moderate High Low
Awareness of
Immunotherapy Moderate Low High Low
Willingness to
receive
immunotherapy
Willing Doubting Willing Unwilling
Involvement in
treatment decisions Moderate Low High Low
Compliance with
allergy treatments Compliant
Somewhat
compliant Compliant Non-compliant
Patient Segments
38% 29% 21% 12%
![Page 16: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/16.jpg)
Breakouts
16 16
![Page 17: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/17.jpg)
Segment Role-Play Name the segment…
17 17
![Page 18: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/18.jpg)
18 18
Patient Videos Name the segment…
18
Watch the video at http://youtu.be/sIuSlLR5om4.
![Page 19: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/19.jpg)
Accepting Doubters Optimists Unmotivated
Knowledge Level of
Current Allergies High Moderate High Low
Awareness of
Immunotherapy Moderate Low High Low
Willingness to
receive
immunotherapy
Willing Doubting Willing Unwilling
Involvement in
treatment decisions Moderate Low High Low
Compliance with
allergy treatments Compliant
Somewhat
compliant Compliant Non-compliant
Patient Segments
19 19 19
38% 29% 21% 12%
![Page 20: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/20.jpg)
20
Patient Immersion Wrap-up
20
![Page 21: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/21.jpg)
Revisiting The Cone of Learning
21
After 2 weeks,
We tend to remember…
P
A
S
S
I
V
E
A
C
T
I
V
E
10% of what we READ
20% of what we HEAR
30% of what we SEE
50% of what we
SEE & HEAR
70% of what
we SAY
90% of what
we SAY & DO
Reading
Hearing
Words
Seeing
Watching a Movie
Looking at an Exhibit
Watching a Demonstration
Seeing it Done on Location
Participating in a Discussion
Giving a Talk
Doing a Dramatic Presentation
Simulating the Real Experience
Doing the Real Thing
Source: Edgar Dale (1969)
![Page 22: Making market research actionable: ensuring that key stakeholders deeply experience and act upon insights](https://reader035.vdocument.in/reader035/viewer/2022062706/55764d7dd8b42aaa548b45c5/html5/thumbnails/22.jpg)
I see and I forget.
I hear and I remember.
I do and I understand. – Confucius
22